These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23018795)

  • 41. Formation of 3-hydroxy-2,3-dihydrovitamin K1 in vivo: relationship to vitamin K epoxide reductase and warfarin resistance.
    Preusch PC; Suttie JW
    J Nutr; 1984 May; 114(5):902-10. PubMed ID: 6726460
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structure and function of vitamin K epoxide reductase.
    Tie JK; Stafford DW
    Vitam Horm; 2008; 78():103-30. PubMed ID: 18374192
    [TBL] [Abstract][Full Text] [Related]  

  • 43. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors.
    Wallin R; Wajih N; Hutson SM
    Vitam Horm; 2008; 78():227-46. PubMed ID: 18374197
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence of a target resistance to antivitamin K rodenticides in the roof rat Rattus rattus: identification and characterisation of a novel Y25F mutation in the Vkorc1 gene.
    Goulois J; Chapuzet A; Lambert V; Chatron N; Tchertanov L; Legros L; Benoît E; Lattard V
    Pest Manag Sci; 2016 Mar; 72(3):544-50. PubMed ID: 25847836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel insight into the mechanism of the vitamin K oxidoreductase (VKOR): electron relay through Cys43 and Cys51 reduces VKOR to allow vitamin K reduction and facilitation of vitamin K-dependent protein carboxylation.
    Rishavy MA; Usubalieva A; Hallgren KW; Berkner KL
    J Biol Chem; 2011 Mar; 286(9):7267-78. PubMed ID: 20978134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. VKORC1L1, An Enzyme Mediating the Effect of Vitamin K in Liver and Extrahepatic Tissues.
    Lacombe J; Ferron M
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30050002
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Disulfide-dependent protein folding is linked to operation of the vitamin K cycle in the endoplasmic reticulum. A protein disulfide isomerase-VKORC1 redox enzyme complex appears to be responsible for vitamin K1 2,3-epoxide reduction.
    Wajih N; Hutson SM; Wallin R
    J Biol Chem; 2007 Jan; 282(4):2626-35. PubMed ID: 17124179
    [TBL] [Abstract][Full Text] [Related]  

  • 48. VKORC1 and the vitamin K cycle.
    Garcia AA; Reitsma PH
    Vitam Horm; 2008; 78():23-33. PubMed ID: 18374188
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low warfarin resistance frequency in Norway rats in two cities in China after 30 years of usage of anticoagulant rodenticides.
    Ma X; Wang D; Li N; Liu L; Tian L; Luo C; Cong L; Feng Z; Liu XH; Song Y
    Pest Manag Sci; 2018 Nov; 74(11):2555-2560. PubMed ID: 29667309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vitamin K 2,3-epoxide reductase and the vitamin K-dependent gamma-carboxylation system.
    Wallin R; Sane DC; Hutson SM
    Thromb Res; 2002 Nov; 108(4):221-6. PubMed ID: 12617985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver.
    Hildebrandt EF; Suttie JW
    Biochemistry; 1982 May; 21(10):2406-11. PubMed ID: 6807339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
    Chu PH; Huang TY; Williams J; Stafford DW
    Proc Natl Acad Sci U S A; 2006 Dec; 103(51):19308-13. PubMed ID: 17164330
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inhibition of bacterial disulfide bond formation by the anticoagulant warfarin.
    Dutton RJ; Wayman A; Wei JR; Rubin EJ; Beckwith J; Boyd D
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):297-301. PubMed ID: 20018758
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin K1 hydroquinone formation catalyzed by a microsomal reductase system.
    Fasco MJ; Principe LM
    Biochem Biophys Res Commun; 1980 Dec; 97(4):1487-92. PubMed ID: 7213374
    [No Abstract]   [Full Text] [Related]  

  • 55. The long-term effects of the rodenticide, brodifacoum, on blood coagulation and vitamin K metabolism in rats.
    Mosterd JJ; Thijssen HH
    Br J Pharmacol; 1991 Oct; 104(2):531-5. PubMed ID: 1797316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Temporal variation in the effects of warfarin on the vitamin K cycle.
    Soulban G; Labrecque G; Bélanger PM
    Chronobiol Int; 1990; 7(5-6):403-11. PubMed ID: 2097073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of oral anticoagulants with vitamin K epoxide reductase in its native milieu.
    Chen X; Jin DY; Stafford DW; Tie JK
    Blood; 2018 Nov; 132(18):1974-1984. PubMed ID: 30089628
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Stabilization of warfarin-binding pocket of VKORC1 and VKORL1 by a peripheral region determines their different sensitivity to warfarin inhibition.
    Shen G; Li S; Cui W; Liu S; Liu Q; Yang Y; Gross M; Li W
    J Thromb Haemost; 2018 Jun; 16(6):1164-1175. PubMed ID: 29665197
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin.
    Thijssen HH
    Biochem Pharmacol; 1987 Sep; 36(17):2753-7. PubMed ID: 3632704
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vitamin K metabolism and vitamin K1 status in human liver samples: a search for inter-individual differences in warfarin sensitivity.
    Thijssen HH; Drittij-Reijnders MJ
    Br J Haematol; 1993 Aug; 84(4):681-5. PubMed ID: 8217828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.